MUMBAI, India, Jan. 17 -- Intellectual Property India has published a patent application (202417101264 A) filed by Kissei Pharmaceutical Co. Ltd., Nagano, Japan, on Dec. 20, 2024, for '3,4-dihydroquinolin-2(1h)-one compound.'
Inventor(s) include Mutai, Yosuke; Ishikawa, Takehiro; Itou, Tatsuya; Matsumoto, Kyohei; and Tanada, Fumiya.
The application for the patent was published on Jan. 17, under issue no. 03/2025.
According to the abstract released by the Intellectual Property India: "The present invention addresses the problem of providing a novel compound that has a thyroid-stimulating hormone receptor antagonist activity and is useful for the treatment of thyroid-related diseases. The present invention relates to a 3,4-dihydroquinolin-...